Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity |
Investigator |
Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants with Previously Treated Locally Advanced/Metastatic or Surgically Unresectable.. | Contract | $171,440.00 | Clinical Trial | Aaron Scott | Cancer Center Division | Incyte Corporation | 05/2020 |
| Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-Type, Left-Sided Colorectal Cancer | Contract | $127,173.74 | Clinical Trial | Aaron Scott | Cancer Center Division | Academic Gastrointestinal Cancer Consortium | 03/2020 |
| A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Naive Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel.. | Contract | $327,830.00 | Clinical Trial | Abhijeet Kumar | Cancer Center Division | Covance, Incorporated | 01/2020 |
| A Phase II Trial of PET-Directed Therapy using AVD (Doxorubicin, Vinblastine, and Dacarbazine) Plus Brentuximab Vedotin Induction Chemotherapy, with or without Brentuximab Vedotin Plus Nivolumab, Foll | Contract | $40,100.00 | Clinical Trial | Abhijeet Kumar | Cancer Center Division | Mayo Foundation for Medical Education and Research (Mayo Clinic) | 06/2020 |
| Accuracy of Arthroscopic vs. Open Reduction of Ankle Syndesmosis Injuries | Contract | $5,000.00 | Research Training | Aditya Manoharan | Orthopaedic Surgery | Orthopaedic Research and Education Foundation | 04/2020 |
| A Novel Approach to Help Women of Reproductive Age Quit Smoking | Grant | $100,000.00 | Research | Alicia Allen | Family and Community Medicine | Prevent Cancer Foundation | 04/2020 |
| Arizona Anesthesia Solutions Professional Agreement | Contract | $499,200.00 | Other Sponsored Activity | Allen Prettyman | College of Nursing | Arizona Anesthesia Solutions | 08/2020 |
| Regulation of P-Body Formation and mRNA Decapping in Cancer: Control by AKT and Pim Kinase Phosphorylation of EDC3 | Grant | $394,690.00 | Research | Andrew Kraft | Cancer Center Division | National Cancer Institute | 07/2020 |
| In Vivo Screening of Candidate Therapeutic Antibodies in Preclinical Models of Prostate Cancer | Contract | $31,231.00 | Research | Anne Cress | Cellular & Molecular Medicine | Aqualung Therapeutics, Corp. | 02/2020 |
| The Role of Ryanodine Receptors in Drug Seeking | Grant | $1,430,743.00 | Research | Arthur Riegel | Pharmacology | National Institute on Drug Abuse | 02/2020 |
| The MITRAL Trial (Mitral Implantation of TRAnscatheter VaLves is Native Mitral Stenosis) | Contract | $62,000.00 | Clinical Trial | Ashish Pershad | COM Phx Internal Medicine | Mayo Foundation for Medical Education and Research (Mayo Clinic) | 01/2020 |
| A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair with the Edwards PASCAL Transcatheter ...... | Contract | $141,792.00 | Clinical Trial | Ashish Pershad | COM Phx Internal Medicine | Edwards Lifesciences LLC | 06/2020 |
| Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms | Contract | $194,732.72 | Clinical Trial | Ashish Pershad | COM Phx Internal Medicine | BioVentrix, Inc. | 08/2020 |
| ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE in Subjects InDicatEd for TAVR | Contract | $115,544.00 | Clinical Trial | Ashish Pershad | COM Phx Internal Medicine | Boston Scientific Corporation | 03/2020 |
| IPA Agreement for Dr. Ashwani Gupta | Contract | $75,884.00 | Research | Ashwani Gupta | Surgery | United States Department of Veterans Affairs | 07/2020 |
| A Multicenter, Double-Blind, Multidose, Placebo-Controlled, Randomized, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 for Patients with Brain Contusion | Contract | $96,267.00 | Clinical Trial | Bellal Joseph | Surgery | Biogen Incorporated | 03/2020 |
| A Prospective, Randomized, Open-Label, Comparative Study to Assess the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) and Best Available Therapy for the Treatment of Serious... | Contract | $240,575.50 | Clinical Trial | Bellal Joseph | Surgery | Parexel International Corporation | 03/2020 |
| Exploring the Neurobiology of the Premonitory Phase of Migraine Preclinically | Contract | $149,875.50 | Research | Caroline Kopruszinski | Pharmacology | Amgen | 01/2020 |
| Yuma County Contact Tracing | Contract | $252,435.00 | Other Sponsored Activity | Cecilia Rosales | Public Hlth Pract & Trans Rsch | Yuma County Public Health Services District | 07/2020 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate The Efficacy and Safety of Anamorelin HCL for the Treatment OF Malignancy Associated Weight Loss and Anorexia... | Contract | $42,626.00 | Clinical Trial | Charles Hsu | Cancer Center Division | PSI Pharma Support America, Incorporated | 01/2020 |
| A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with... | Contract | $1,278,228.50 | Clinical Trial | Charles Hsu | Radiation Oncology | Astrazeneca | 08/2020 |
| Patient-Specific iPSCs-Derived Vascularized Organoids for Investigating Differential Susceptibility to E-cigarette | Fellowship | $135,352.00 | Research Training | Chen-wei Liu | COM Phx Basic Medical Sci | American Heart Association, Incorporated | 01/2020 |
| Mechanisms for Intracranial Aneurysm Rupture | Grant | $52,190.00 | Research | Chengcheng Hu | Epidemiology and Biostatistics | Saint Joseph's Hospital and Medical Center | 06/2020 |
| A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 with Placebo and with Tofacitinib in Combination with Conventional Synthetic DMARDs.... | Contract | $314,050.00 | Clinical Trial | Chian Kwoh | Arthritis Center-Research | IQVIA RDS Inc. | 03/2020 |
| A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients with Diffuse Cutaneous Systemic Sclerosis or Systemic Sclerosis-Associated... | Contract | $55,928.00 | Clinical Trial | Chian Kwoh | Arthritis Center-Research | Cumberland Pharmaceuticals, Incorporated | 07/2020 |